Ipsen Acquisition Trifecta Raises North American Stakes
This article was originally published in The Pink Sheet Daily
Executive Summary
French drug maker takes control of Tercica, Vernalis’ U.S. subsidiary and Octagen’s investigational hemophilia drug OB-1.